Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Coiffier

Showing results (121-130 of 249) with videos related to

Pageof 25
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|March 2, 2010
Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic IndexEwa Lech-Maranda, Jacques Bienvenu, Florence Broussais-Guillaumot, et al.
Leukemia & Lymphoma|January 21, 2012
Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasmLila Gilis, Laure Lebras, Fadhela Bouafia-Sauvy, et al.
Cancer|December 24, 2009
Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study GroupIrene Biasoli, Aspasia Stamatoullas, Véronique Meignin, et al.
Leukemia & Lymphoma|April 6, 2011
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplantNatacha Heutte, Corinne Haioun, Pierre Feugier, et al.
Leukemia & Lymphoma|April 12, 2003
Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001Catherine Thieblemont, Charles Dumontet, Fadhela Bouafia, et al.
Mabs|June 12, 2012
7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, FrancePetrus J Pauwels, Charles Dumontet, Janice M Reichert, et al.
Investigational New Drugs|January 21, 2015
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemiaFranck Morschhauser, Louis Terriou, Bertrand Coiffier, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 4, 2013
Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphomaEwa Lech-Maranda, Jacques Bienvenu, Florence Broussais-Guillaumot, et al.
Clinical Lymphoma|July 27, 2002
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patientsCatherine Thieblemont, Pascale Felman, Francoise Berger, et al.
Haematologica|January 29, 2003
Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphomaSophie Gazzo, Lucile Baseggio, Lionel Coignet, et al.
Pageof 25

Showing results (121-130 of 249) with videos related to

Sort By:
Pageof 25
Archivum Immunologiae Et Therapiae Experimentalis|March 2, 2010
Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic IndexEwa Lech-Maranda, Jacques Bienvenu, Florence Broussais-Guillaumot, et al.
Leukemia & Lymphoma|January 21, 2012
Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasmLila Gilis, Laure Lebras, Fadhela Bouafia-Sauvy, et al.
Cancer|December 24, 2009
Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study GroupIrene Biasoli, Aspasia Stamatoullas, Véronique Meignin, et al.
Leukemia & Lymphoma|April 6, 2011
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplantNatacha Heutte, Corinne Haioun, Pierre Feugier, et al.
Leukemia & Lymphoma|April 12, 2003
Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001Catherine Thieblemont, Charles Dumontet, Fadhela Bouafia, et al.
Mabs|June 12, 2012
7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, FrancePetrus J Pauwels, Charles Dumontet, Janice M Reichert, et al.
Investigational New Drugs|January 21, 2015
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemiaFranck Morschhauser, Louis Terriou, Bertrand Coiffier, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 4, 2013
Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphomaEwa Lech-Maranda, Jacques Bienvenu, Florence Broussais-Guillaumot, et al.
Clinical Lymphoma|July 27, 2002
Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patientsCatherine Thieblemont, Pascale Felman, Francoise Berger, et al.
Haematologica|January 29, 2003
Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphomaSophie Gazzo, Lucile Baseggio, Lionel Coignet, et al.
Pageof 25